Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Intracellular RNA-tracking methods.

George L, Indig FE, Abdelmohsen K, Gorospe M.

Open Biol. 2018 Oct 3;8(10). pii: 180104. doi: 10.1098/rsob.180104. Review.

2.

Insulin Is Transcribed and Translated in Mammalian Taste Bud Cells.

Doyle ME, Fiori JL, Gonzalez Mariscal I, Liu QR, Goodstein E, Yang H, Shin YK, Santa-Cruz Calvo S, Indig FE, Egan JM.

Endocrinology. 2018 Sep 1;159(9):3331-3339. doi: 10.1210/en.2018-00534.

PMID:
30060183
3.

Identification of senescent cell surface targetable protein DPP4.

Kim KM, Noh JH, Bodogai M, Martindale JL, Yang X, Indig FE, Basu SK, Ohnuma K, Morimoto C, Johnson PF, Biragyn A, Abdelmohsen K, Gorospe M.

Genes Dev. 2017 Aug 1;31(15):1529-1534. doi: 10.1101/gad.302570.117. Epub 2017 Sep 6.

4.

Concurrent activation of β2-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.

Wnorowski A, Such J, Paul RK, Wersto RP, Indig FE, Jozwiak K, Bernier M, Wainer IW.

Cell Signal. 2017 Aug;36:176-188. doi: 10.1016/j.cellsig.2017.05.006. Epub 2017 May 8.

5.

Probing extracellular Sonic hedgehog in neurons.

Eitan E, Petralia RS, Wang YX, Indig FE, Mattson MP, Yao PJ.

Biol Open. 2016 Aug 15;5(8):1086-92. doi: 10.1242/bio.019422.

6.

HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP.

Noh JH, Kim KM, Abdelmohsen K, Yoon JH, Panda AC, Munk R, Kim J, Curtis J, Moad CA, Wohler CM, Indig FE, de Paula W, Dudekula DB, De S, Piao Y, Yang X, Martindale JL, de Cabo R, Gorospe M.

Genes Dev. 2016 May 15;30(10):1224-39. doi: 10.1101/gad.276022.115. Epub 2016 May 19.

7.

Induction of VEGFA mRNA translation by CoCl2 mediated by HuR.

Osera C, Martindale JL, Amadio M, Kim J, Yang X, Moad CA, Indig FE, Govoni S, Abdelmohsen K, Gorospe M, Pascale A.

RNA Biol. 2015;12(10):1121-30. doi: 10.1080/15476286.2015.1085276. Epub 2015 Sep 1.

8.

The development of mitochondrial membrane affinity chromatography columns for the study of mitochondrial transmembrane proteins.

Habicht KL, Singh NS, Indig FE, Wainer IW, Moaddel R, Shimmo R.

Anal Biochem. 2015 Sep 1;484:154-61. doi: 10.1016/j.ab.2015.05.018. Epub 2015 Jun 4.

9.

(R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility.

Paul RK, Wnorowski A, Gonzalez-Mariscal I, Nayak SK, Pajak K, Moaddel R, Indig FE, Bernier M, Wainer IW.

Biochem Pharmacol. 2014 Feb 15;87(4):547-61. doi: 10.1016/j.bcp.2013.11.020. Epub 2013 Dec 16.

10.

Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.

O'Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A, Li L, Herlyn M, Villanueva J, Liu Q, Yin X, Widura S, Nelson J, Ruiz N, Camilli TC, Indig FE, Flaherty KT, Wargo JA, Frederick DT, Cooper ZA, Nair S, Amaravadi RK, Schuchter LM, Karakousis GC, Xu W, Xu X, Weeraratna AT.

Cancer Discov. 2013 Dec;3(12):1378-93. doi: 10.1158/2159-8290.CD-13-0005. Epub 2013 Oct 8.

11.

Role of mitofusin 2 (Mfn2) in controlling cellular proliferation.

Chen KH, Dasgupta A, Ding J, Indig FE, Ghosh P, Longo DL.

FASEB J. 2014 Jan;28(1):382-94. doi: 10.1096/fj.13-230037. Epub 2013 Sep 30.

12.

The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRα.

Krzysik-Walker SM, González-Mariscal I, Scheibye-Knudsen M, Indig FE, Bernier M.

Mol Pharmacol. 2013 Jan;83(1):157-66. doi: 10.1124/mol.112.082651. Epub 2012 Oct 12.

13.

Reduction of AP180 and CALM produces defects in synaptic vesicle size and density.

Petralia RS, Wang YX, Indig FE, Bushlin I, Wu F, Mattson MP, Yao PJ.

Neuromolecular Med. 2013 Mar;15(1):49-60. doi: 10.1007/s12017-012-8194-x. Epub 2012 Aug 1.

14.

Nucleolin inhibits G4 oligonucleotide unwinding by Werner helicase.

Indig FE, Rybanska I, Karmakar P, Devulapalli C, Fu H, Carrier F, Bohr VA.

PLoS One. 2012;7(6):e35229. doi: 10.1371/journal.pone.0035229. Epub 2012 Jun 4.

15.

Translational control of TOP2A influences doxorubicin efficacy.

Srikantan S, Abdelmohsen K, Lee EK, Tominaga K, Subaran SS, Kuwano Y, Kulshrestha R, Panchakshari R, Kim HH, Yang X, Martindale JL, Marasa BS, Kim MM, Wersto RP, Indig FE, Chowdhury D, Gorospe M.

Mol Cell Biol. 2011 Sep;31(18):3790-801. doi: 10.1128/MCB.05639-11. Epub 2011 Jul 18.

16.

Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.

Camilli TC, Xu M, O'Connell MP, Chien B, Frank BP, Subaran S, Indig FE, Morin PJ, Hewitt SM, Weeraratna AT.

Pigment Cell Melanoma Res. 2011 Feb;24(1):175-86. doi: 10.1111/j.1755-148X.2010.00792.x. Epub 2010 Dec 1.

17.

Zscan4 regulates telomere elongation and genomic stability in ES cells.

Zalzman M, Falco G, Sharova LV, Nishiyama A, Thomas M, Lee SL, Stagg CA, Hoang HG, Yang HT, Indig FE, Wersto RP, Ko MS.

Nature. 2010 Apr 8;464(7290):858-63. doi: 10.1038/nature08882. Epub 2010 Mar 24.

18.

Functional significance for a heterogenous ribonucleoprotein A18 signature RNA motif in the 3'-untranslated region of ataxia telangiectasia mutated and Rad3-related (ATR) transcript.

Yang R, Zhan M, Nalabothula NR, Yang Q, Indig FE, Carrier F.

J Biol Chem. 2010 Mar 19;285(12):8887-93. doi: 10.1074/jbc.M109.013128. Epub 2010 Jan 26.

19.

The Nucleolus Takes Control of Protein Trafficking Under Cellular Stress.

Nalabothula N, Indig FE, Carrier F.

Mol Cell Pharmacol. 2010;2(5):203-212.

20.

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.

O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, French AD, Dissanayake SK, Indig FE, Bernier M, Taub DD, Hewitt SM, Weeraratna AT.

Oncogene. 2010 Jan 7;29(1):34-44. doi: 10.1038/onc.2009.305. Epub 2009 Oct 5.

21.

Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.

O'Connell MP, Fiori JL, Kershner EK, Frank BP, Indig FE, Taub DD, Hoek KS, Weeraratna AT.

J Biol Chem. 2009 Oct 16;284(42):28704-12. doi: 10.1074/jbc.M109.028498. Epub 2009 Aug 20.

22.

Tregs utilize beta-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation.

Baatar D, Olkhanud PB, Wells V, Indig FE, Mallucci L, Biragyn A.

Brain Behav Immun. 2009 Oct;23(7):1028-37. doi: 10.1016/j.bbi.2009.06.003. Epub 2009 Jun 9.

23.

PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells.

French AD, Fiori JL, Camilli TC, Leotlela PD, O'Connell MP, Frank BP, Subaran S, Indig FE, Taub DD, Weeraratna AT.

Int J Med Sci. 2009;6(2):93-101. Epub 2009 Mar 12.

24.

Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells.

Fiori JL, Zhu TN, O'Connell MP, Hoek KS, Indig FE, Frank BP, Morris C, Kole S, Hasskamp J, Elias G, Weeraratna AT, Bernier M.

Endocrinology. 2009 Jun;150(6):2551-60. doi: 10.1210/en.2008-1344. Epub 2009 Feb 12.

25.

Wnt5A activates the calpain-mediated cleavage of filamin A.

O'Connell MP, Fiori JL, Baugher KM, Indig FE, French AD, Camilli TC, Frank BP, Earley R, Hoek KS, Hasskamp JH, Elias EG, Taub DD, Bernier M, Weeraratna AT.

J Invest Dermatol. 2009 Jul;129(7):1782-9. doi: 10.1038/jid.2008.433. Epub 2009 Jan 29.

26.

Nucleolin Binds to the Proliferating Cell Nuclear Antigen and Inhibits Nucleotide Excision Repair.

Yang C, Kim MS, Chakravarty D, Indig FE, Carrier F.

Mol Cell Pharmacol. 2009;1(3):130-137.

27.

Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells.

D'Souza T, Indig FE, Morin PJ.

Exp Cell Res. 2007 Sep 10;313(15):3364-75. Epub 2007 Jul 13.

28.

Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase.

Imam SZ, Indig FE, Cheng WH, Saxena SP, Stevnsner T, Kufe D, Bohr VA.

Nucleic Acids Res. 2007;35(15):4941-51. Epub 2007 Jul 11.

29.

Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunity.

Biragyn A, Schiavo R, Olkhanud P, Sumitomo K, King A, McCain M, Indig FE, Almanzar G, Baatar D.

J Immunol. 2007 Jul 15;179(2):1381-8.

30.

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.

Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, Taub DD, Trent JM, Moon RT, Bittner M, Weeraratna AT.

J Biol Chem. 2007 Jun 8;282(23):17259-71. Epub 2007 Apr 10.

31.

Psoralen conjugates for visualization of genomic interstrand cross-links localized by laser photoactivation.

Thazhathveetil AK, Liu ST, Indig FE, Seidman MM.

Bioconjug Chem. 2007 Mar-Apr;18(2):431-7.

PMID:
17373769
32.

The Werner syndrome protein is required for recruitment of chromatin assembly factor 1 following DNA damage.

Jiao R, Harrigan JA, Shevelev I, Dietschy T, Selak N, Indig FE, Piotrowski J, Janscak P, Bohr VA, Stagljar I.

Oncogene. 2007 May 31;26(26):3811-22. Epub 2006 Dec 18.

PMID:
17173071
33.

Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.

Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ, Taub DD, Kallioniemi OP, Meltzer P, Morin PJ, Weeraratna AT.

Oncogene. 2007 May 31;26(26):3846-56. Epub 2006 Dec 11.

PMID:
17160014
34.

Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses.

Schiavo R, Baatar D, Olkhanud P, Indig FE, Restifo N, Taub D, Biragyn A.

Blood. 2006 Jun 15;107(12):4597-605. Epub 2006 Mar 2.

35.

Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1.

López de Silanes I, Galbán S, Martindale JL, Yang X, Mazan-Mamczarz K, Indig FE, Falco G, Zhan M, Gorospe M.

Mol Cell Biol. 2005 Nov;25(21):9520-31.

36.

Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress.

Thorslund T, von Kobbe C, Harrigan JA, Indig FE, Christiansen M, Stevnsner T, Bohr VA.

Mol Cell Biol. 2005 Sep;25(17):7625-36.

37.

Regulation of WRN helicase activity in human base excision repair.

Ahn B, Harrigan JA, Indig FE, Wilson DM 3rd, Bohr VA.

J Biol Chem. 2004 Dec 17;279(51):53465-74. Epub 2004 Sep 22.

38.

Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion.

Indig FE, Partridge JJ, von Kobbe C, Aladjem MI, Latterich M, Bohr VA.

J Struct Biol. 2004 Apr-May;146(1-2):251-9.

PMID:
15037256
39.

Werner protein stimulates topoisomerase I DNA relaxation activity.

Laine JP, Opresko PL, Indig FE, Harrigan JA, von Kobbe C, Bohr VA.

Cancer Res. 2003 Nov 1;63(21):7136-46.

40.

DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP.

Partridge JJ, Lopreiato JO Jr, Latterich M, Indig FE.

Mol Biol Cell. 2003 Oct;14(10):4221-9. Epub 2003 Aug 22.

41.

Organelle membrane fusion: a novel function for the syntaxin homolog Ufe1p in ER membrane fusion.

Patel SK, Indig FE, Olivieri N, Levine ND, Latterich M.

Cell. 1998 Mar 6;92(5):611-20.

42.
43.

Calpain cleavage of the cytoplasmic domain of the integrin beta 3 subunit.

Du X, Saido TC, Tsubuki S, Indig FE, Williams MJ, Ginsberg MH.

J Biol Chem. 1995 Nov 3;270(44):26146-51.

44.

Hydrolysis of thymic humoral factor gamma 2 by neutral endopeptidase (EC 3.4.24.11).

Indig FE, Pecht M, Trainin N, Burstein Y, Blumberg S.

Biochem J. 1991 Sep 15;278 ( Pt 3):891-4.

45.

Neutral endopeptidase (EC 3.4.24.11) is highly expressed on osteoblastic cells and other marrow stromal cell types.

Indig FE, Benayahu D, Fried A, Wientroub S, Blumberg S.

Biochem Biophys Res Commun. 1990 Oct 30;172(2):620-6.

PMID:
2241957
46.

Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance.

Skolovsky M, Galron R, Kloog Y, Bdolah A, Indig FE, Blumberg S, Fleminger G.

Proc Natl Acad Sci U S A. 1990 Jun;87(12):4702-6.

47.

Investigation of neutral endopeptidases (EC 3.4.24.11) and of neutral proteinases (EC 3.4.24.4) using a new sensitive two-stage enzymatic reaction.

Indig FE, Ben-Meir D, Spungin A, Blumberg S.

FEBS Lett. 1989 Sep 25;255(2):237-40. Erratum in: FEBS Lett 1990 Feb 12;261(1):217.

Supplemental Content

Loading ...
Support Center